A Multicenter, Double-Blind, Randomized, Comparison Study Of The Efficacy And Safety Of Tigecycline To Imipenem/Cilastatin To Treat Complicated Intra-Abdominal Infections In Hospitalized Subjects

Trial Profile

A Multicenter, Double-Blind, Randomized, Comparison Study Of The Efficacy And Safety Of Tigecycline To Imipenem/Cilastatin To Treat Complicated Intra-Abdominal Infections In Hospitalized Subjects

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Mar 2016

At a glance

  • Drugs Tigecycline (Primary) ; Imipenem/cilastatin
  • Indications Bacterial infections; Intra-abdominal infections
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 23 Feb 2016 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
    • 04 Feb 2016 Planned End Date changed to 1 Feb 2016 as reported by ClinicalTrial.gov record.
    • 04 Feb 2016 Planned primary completion date changed to 1 Feb 2016 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top